LightForce Orthodontics has named Erica Rogers as its new chief executive officer, marking a leadership transition aimed at accelerating the commercial adoption of its Generative Braces platform. The appointment comes as the company surpasses 200,000 patient treatments with its personalized 3D-printed orthodontic system and looks to scale operations across the estimated $10 billion global orthodontics market.

Digital orthodontics company LightForce Orthodontics has appointed medical technology executive Erica Rogers as chief executive officer, signaling a strategic shift from product validation to large-scale commercial expansion for its AI-enabled, fully customized orthodontic platform.

Rogers takes over leadership as the company seeks to broaden the adoption of its Generative Braces system, a digitally driven orthodontic solution that combines individualized treatment planning, patient-specific brackets, direct 3D printing, and precision placement workflows. The move reflects a broader trend across healthcare technology, where personalized manufacturing and digital treatment planning are reshaping traditional clinical practices.

The leadership change follows an important milestone for the company, which says more than 200,000 patients have been treated using its customized orthodontic brackets. The figure highlights growing acceptance of digitally manufactured orthodontic appliances as providers increasingly adopt technologies that enable more personalized care.

Unlike conventional orthodontic systems that rely on standardized bracket prescriptions, LightForce's platform generates a customized prescription for every individual tooth based on an orthodontist's treatment objectives. Each ceramic or metal bracket is manufactured through direct 3D printing, allowing clinicians to align fixed braces with patient-specific anatomy and treatment plans.

This personalized approach mirrors a wider transformation occurring throughout healthcare, where advances in artificial intelligence, digital imaging, additive manufacturing, and data-driven treatment planning are enabling clinicians to tailor therapies to individual patients rather than standardized protocols.

LightForce positions its Generative Braces platform as part of an end-to-end digital workflow that complements modern aligner therapy. The integration of digital treatment planning with additive manufacturing allows orthodontists to streamline case planning while maintaining the clinical advantages of fixed braces.

Rogers brings more than three decades of leadership experience in medical technology commercialization. Most recently, she served as chief executive officer of Silk Road Medical, where she oversaw the company's commercial growth, public market debut, and eventual acquisition by Boston Scientific. She has also served on LightForce's board of directors for the past two years, providing familiarity with the company's technology roadmap, customer base, and long-term growth strategy.

Her appointment reflects a common pattern among emerging healthcare technology companies that transition from founder-led innovation toward experienced executives with expertise in scaling commercial operations, expanding manufacturing, and driving global market adoption.

Founder Alfred Griffin, who pioneered the Generative Braces category in 2019, will remain actively involved as chairman of the board and assume the role of chief product officer. In that position, Griffin will continue leading product innovation, technology development, and clinical advocacy while working alongside Rogers on commercialization and strategic growth.

The transition allows LightForce to separate product innovation from commercial execution, a structure frequently adopted by high-growth medical technology companies as they mature.

The company plans to prioritize three strategic initiatives under Rogers' leadership: expanding adoption of Generative Braces, increasing manufacturing capacity, and advancing its portfolio of customized ceramic and metal orthodontic products.

The broader orthodontics market is undergoing significant digital transformation. Technologies including 3D printing, computer-aided design (CAD), artificial intelligence, and cloud-based treatment planning are changing how orthodontic appliances are designed, manufactured, and delivered. These innovations are reducing manual processes while improving treatment precision and workflow efficiency.

Major healthcare technology providers and digital dentistry companies continue investing heavily in personalized treatment platforms, reflecting increasing demand for customized patient care. Similar digital manufacturing strategies are also being adopted across orthopedic implants, dental prosthetics, surgical guides, and other patient-specific medical devices.

According to Grand View Research, the global 3D printing healthcare market continues to expand as healthcare providers adopt additive manufacturing for customized medical devices and precision treatment solutions. Meanwhile, McKinsey & Company has identified personalized medicine and digitally enabled healthcare delivery as key long-term growth areas across the medical technology industry.

From a technology perspective, LightForce's platform represents the convergence of AI-assisted treatment planning, digital manufacturing, and mass customization—three trends that are increasingly defining the future of healthcare innovation. Rather than producing identical devices at scale, manufacturers are leveraging software-driven production systems capable of creating individualized products efficiently.

For orthodontic practices, this evolution may improve workflow efficiency, reduce manual customization, and provide clinicians with greater flexibility in treatment planning. For patients, personalized appliances have the potential to support more precise treatment approaches while maintaining the clinical familiarity of traditional fixed braces.

LightForce's leadership transition therefore extends beyond executive succession. It reflects the company's ambition to establish personalized, digitally manufactured orthodontics as a mainstream standard of care while scaling production capabilities to meet growing global demand for customized healthcare technologies.

Market Landscape

Digital dentistry and personalized medical technologies are reshaping orthodontics through AI-assisted treatment planning and additive manufacturing. Grand View Research projects continued growth in healthcare 3D printing as providers adopt customized medical devices and precision manufacturing. McKinsey & Company also identifies personalized healthcare and digital clinical workflows as long-term drivers of medical technology investment, encouraging companies to scale AI-enabled manufacturing and patient-specific treatment solutions.

Top Insights

• LightForce has appointed Erica Rogers as CEO to accelerate commercial expansion of its Generative Braces platform across the global orthodontics market.
• The company has treated more than 200,000 patients, demonstrating growing adoption of personalized 3D-printed orthodontic technology.
• Generative Braces combine AI-assisted treatment planning, digital workflows, and additive manufacturing to create patient-specific orthodontic appliances.
• Founder Alfred Griffin will transition to chief product officer, focusing on innovation while Rogers leads commercial growth and manufacturing expansion.
• The announcement reflects broader healthcare trends toward personalized medicine, digital dentistry, and scalable AI-enabled medical device manufacturing.

Get in touch with our MarTech Experts